Compound I Is the Reactive Intermediate in the First Monooxygenation Step during Conversion of Cholesterol to Pregnenolone by Cytochrome P450scc: EPR/ENDOR/Cryoreduction/Annealing Studies (Q36378971)
scientific article published on October 5, 2012
Language:
(P31) (Q13442814)
(P50) (Q87642277)
(P304) 17149-17156
(P407) (Q1860)
(P433) 41
(P478) 134
(P577) Friday, October 5, 2012
(P953) https://europepmc.org/articles/pmc3491644?pdf=render
https://europepmc.org/articles/PMC3491644
https://europepmc.org/articles/PMC3491644?pdf=render
https://doi.org/10.1021/ja3067226
https://pubs.acs.org/doi/pdf/10.1021/ja3067226
(P1433) (Q898902)
(P1476) "Compound I is the reactive intermediate in the first monooxygenation step during conversion of cholesterol to pregnenolone by cytochrome P450scc: EPR/ENDOR/cryoreduction/annealing studies" (language: en)
"Compound I Is the Reactive Intermediate in the First Monooxygenation Step during Conversion of Cholesterol to Pregnenolone by Cytochrome P450scc: EPR/ENDOR/Cryoreduction/Annealing Studies" (language: en)
(P2093) Roman Davydov
Natallia V. Strushkevich
Sergey A. Usanov
Brian M. Hoffman
(P2860) (Q24305250)
(Q27666316)
(Q34149381)
(Q37790461)
(Q37771486)
(Q37766022)
(Q33615596)
(Q33503307)
(Q37366162)
(Q27640961)
(Q36154632)
(Q36095283)
(Q35961100)
(Q34796667)
(Q30771015)
(Q27621595)
(Q40898439)
(Q40211234)
(Q42369517)
(Q42734142)
(Q42264562)
(Q43117590)
(Q43261631)
(Q43096189)
(Q46633561)
(Q45247708)
(Q45177605)
(Q44898761)
(Q44704268)
(Q45712309)
(Q46030918)
(Q43859287)
(Q43677243)
(Q57631664)
(Q58095124)
(Q57397972)
(Q73169661)
(Q72861271)
(Q74393418)
(Q4086944)
other details
description scientific article published on October 5, 2012

External Links